Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer prognostics: Past, present and p27

Reduced expression of the p27 cell cycle inhibitor predicts poor cancer patient survival (pages 222–234).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Catzavelos, C. et al. Decreased levels of the cell cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature Med. 3, 227–230 (1997).

    Article  CAS  Google Scholar 

  2. Porter, P. et al. Expression of cell cycle regulators p27 Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222–226 (1997).

    Article  CAS  Google Scholar 

  3. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231–234 (1997).

    Article  CAS  Google Scholar 

  4. Kiyokawa, H. et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1 Cell 85, 721–732 (1996).

    Article  CAS  Google Scholar 

  5. Nakayama, K. et al. Mice lacking p27 Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85, 707–720 (1996).

    Article  CAS  Google Scholar 

  6. Hengst, L. & Reed, S. Translational control of p27 Kip1 accumulation during the cell cycle. Science 271, 1861–1864 (1996).

    Article  CAS  Google Scholar 

  7. Pagano, M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682–685 (1995).

    Article  CAS  Google Scholar 

  8. Muss, H. et al. c-erb-B-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Engl. J. Med. 330, 1260–1266 (1994).

    Article  CAS  Google Scholar 

  9. Thor, A. et al. Selecting patients for higher dose adjuvant CAF: c-erb-B-2, p53 (CALGB 8869 and 8541). Proc. American Society of Clinical Oncology (in the press).

  10. Emmert-Buck, M. et al. Laser capture microdissection. Science 274, 998–1001 (1996).

    Article  CAS  Google Scholar 

  11. To affinity … and beyond! Nature Genet 14, 367–370 (1996).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steeg, P., Abrams, J. Cancer prognostics: Past, present and p27. Nat Med 3, 152–154 (1997). https://doi.org/10.1038/nm0297-152

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0297-152

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing